We want you to be especially careful, as relying on expired semaglutide may hinder your ability to effectively control blood sugar and achieve your weight loss goals
KLOW is not usable in-competition
Formulary approaches may drive utilization of one or the other drug, both of which offer strong weight loss potential Employees should continue to monitor this class of medications as there are additional products in the pipeline, including oral semaglutide for obesity, expected to be FDA approved by the end of 2025
Reading the syringe from above instead of straight on
When using the semaglutide pen either Ozempic or Wegovy, women may have questions about dosages, injection technique, proper injection site rotation, or possible side effects
Foundayo (Orforglipron) Approved in April 2026, Foundayo is a daily oral medication that offers flexibility in dosage timing and minimal restrictions